Next, we used cytarabine-adapted MV4–11 and MOLM-13 sublines to further study the role of SAMHD1 and DCK in cross-resistance of nucleoside analogue-adapted AML cells to CNDAC (Fig. 7E). This evidence concerns the gene SAMHD1 and acute myeloid leukemia.